These benefits, along with a former report showing that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,2 assist the concept of targeting ACKR3 as a unique solution to modulate the opioid process, which could open new therapeutic avenues for opioid-related Problems. Disclaimer: The above mentioned is a https://steveo258rnj7.angelinsblog.com/profile